Also trades as: NRSNW (NASDAQ) · $vol 0M
NRSN NASDAQ
NeuroSense Therapeutics Ltd.
1W: -9.2%
1M: +10.1%
3M: -14.5%
YTD: -0.9%
1Y: -52.6%
3Y: -55.3%
$0.82
+0.05 (+6.08%)
Weekly Expected Move ±8.8%
$1
$1
$1
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$20.2M
52W Range0.63-2.6
Volume71,002
Avg Volume146,934
Beta1.58
Dividend—
Analyst Ratings
Company Info
CEOAlon Ben-Noon
Employees17
SectorHealthcare
IndustryBiotechnology
IPO Date2021-12-09
Websiteneurosense-tx.com
Building B
Herzliya 4672562
IL
Herzliya 4672562
IL
972 9 799 6183
About NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of treatment for patients suffering from debilitating neurodegenerative diseases. Its lead product, PrimeC, is a novel oral formulation that has completed Phase IIa clinical trials for the treatment of amyotrophic lateral sclerosis. The company's preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.
Latest News
NeuroSense Therapeutics receives Nasdaq notices over listing requirements
NeuroSense Therapeutics reports FY results, GAAP EPS of $0.44
NeuroSense Therapeutics Reports Year End 2025 Financial Results and Provides Business Update
This Strategy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
NeuroSense Granted U.S. Patent for Treatment of Alzheimer's Disease
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Eisenberg Or | A-Award | 200,000 | — | 2026-03-26 |
| Russek-Blum Niva | A-Award | 200,000 | — | 2026-03-26 |
| Binder Hagit | A-Award | 200,000 | — | 2026-03-26 |
| Eisenberg Or | 0 | — | 2026-03-18 | |
| Eisenberg Or | 0 | — | 2026-03-18 |